Canakinumab Subcutaneous and Xopenex Inhalation Solution Concentrate
Determining the interaction of Canakinumab Subcutaneous and Xopenex Inhalation Solution Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Xopenex Concentrate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Xopenex Pediatric
- Canakinumab Subcutaneous-Xospata
- Canakinumab Subcutaneous-Xoten-C
- Canakinumab Subcutaneous-Xpect-AT
- Canakinumab Subcutaneous-Xpect-PE
- Canakinumab Subcutaneous-Xpovio
- Xopenex Inhalation Solution Concentrate-Canasa
- Xopenex Inhalation Solution Concentrate-Canasa Pac rectal
- Xopenex Inhalation Solution Concentrate-Canasa rectal
- Xopenex Inhalation Solution Concentrate-Cancidas
- Xopenex Inhalation Solution Concentrate-Candesartan
- Xopenex Inhalation Solution Concentrate-Candesartan and Hydrochlorothiazide